The Concept of Postbiotics

Overview

Journal Foods

Specialty Biotechnology

Date 2022 Apr 23

PMID 35454664

Authors

Gabriel Vinderola

Mary Ellen Sanders

Seppo Salminen

Affiliations

Soon will be listed here.

Abstract

The scientific community has proposed terms such as non-viable probiotics, paraprobiotics, ghostbiotics, heat-inactivated probiotics or, most commonly, postbiotics, to refer to inanimate microorganisms and/or their components that confer health benefits. This article addresses the various characteristics of different definitions of 'postbiotics' that have emerged over past years. In 2021, the International Scientific Association for Probiotics and Prebiotics (ISAPP) defined a postbiotic as "a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host". This definition of postbiotic requires that the whole or components of inactivated microbes be present, with or without metabolic end products. The definition proposed by ISAPP is comprehensive enough to allow the development of postbiotics from different microorganisms, to be applied in different body sites, encouraging innovation in a promising area for any regulatory category and for companion or production animals, and plant or human health. From a technological perspective, probiotic products may contain inanimate microorganisms, which have the potential to impart a health benefit. However, their contribution to health in most cases has not been established, even if at least one probiotic has been shown to confer the same health benefit by live or inanimate cells.

Citing Articles

Clean Label Approaches in Cheese Production: Where Are We?.

Fernandes J, Gomes S, Reboredo F, Pintado M, Amaral O, Dias J Foods. 2025; 14(5).

PMID: 40077507 PMC: 11899541. DOI: 10.3390/foods14050805.

The Characterization of Lactic Acid Bacteria Strains as Components of a Biopreparation for Chickens for Slaughter.

Zamojska D, Rosicka-Kaczmarek J, Macierzynska-Piotrowska E, Nowak A Microorganisms. 2025; 13(2).

PMID: 40005683 PMC: 11857880. DOI: 10.3390/microorganisms13020317.

Yeast Strains as Probiotic and Postbiotic Agents for the Agglutination of Enteric Pathogens: A Preventive Approach.

Cerdan-Alduan M, Salvador-Erro J, Villegas-Remirez A, Garcia-Yoldi D, Ceniceros A, Pastor Y Pathogens. 2025; 14(2).

PMID: 40005490 PMC: 11858296. DOI: 10.3390/pathogens14020113.

Microbiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative Review.

Todor S, Ichim C Children (Basel). 2025; 12(2).

PMID: 40003268 PMC: 11854176. DOI: 10.3390/children12020166.

Immunomodulatory Effects of Selected Non-Nutritive Bioactive Compounds and Their Role in Optimal Nutrition.

Napiorkowska-Baran K, Treichel P, Dardzinska A, Majcherczak A, Pilichowicz A, Szota M Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996810 PMC: 11854453. DOI: 10.3390/cimb47020089.

References

Campeotto F, Suau A, Kapel N, Magne F, Viallon V, Ferraris L . A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA. Br J Nutr. 2011; 105(12):1843-51. DOI: 10.1017/S0007114510005702. View

Sugawara T, Sawada D, Ishida Y, Aihara K, Aoki Y, Takehara I . Regulatory effect of paraprobiotic Lactobacillus gasseri CP2305 on gut environment and function. Microb Ecol Health Dis. 2016; 27:30259. PMC: 4793260. DOI: 10.3402/mehd.v27.30259. View

Binda S, Hill C, Johansen E, Obis D, Pot B, Sanders M . Criteria to Qualify Microorganisms as "Probiotic" in Foods and Dietary Supplements. Front Microbiol. 2020; 11:1662. PMC: 7394020. DOI: 10.3389/fmicb.2020.01662. View

Montane E, Barriocanal A, Arellano A, Valderrama A, Sanz Y, Perez-Alvarez N . Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity. PLoS One. 2017; 12(2):e0171294. PMC: 5300153. DOI: 10.1371/journal.pone.0171294. View

Shoaib M, Shehzad A, Omar M, Rakha A, Raza H, Sharif H . Inulin: Properties, health benefits and food applications. Carbohydr Polym. 2016; 147:444-454. DOI: 10.1016/j.carbpol.2016.04.020. View

Palaria A, Johnson-Kanda I, OSullivan D . Effect of a synbiotic yogurt on levels of fecal bifidobacteria, clostridia, and enterobacteria. Appl Environ Microbiol. 2011; 78(4):933-40. PMC: 3272998. DOI: 10.1128/AEM.05848-11. View

Indrio F, Ladisa G, Mautone A, Montagna O . Effect of a fermented formula on thymus size and stool pH in healthy term infants. Pediatr Res. 2007; 62(1):98-100. DOI: 10.1203/pdr.0b013e31806772d3. View

Aguilar-Toala J, Arioli S, Behare P, Belzer C, Berni Canani R, Chatel J . Postbiotics - when simplification fails to clarify. Nat Rev Gastroenterol Hepatol. 2021; 18(11):825-826. DOI: 10.1038/s41575-021-00521-6. View

Salminen S, Collado M, Endo A, Hill C, Lebeer S, Quigley E . The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021; 18(9):649-667. PMC: 8387231. DOI: 10.1038/s41575-021-00440-6. View

10.

Morisset M, Aubert-Jacquin C, Soulaines P, Moneret-Vautrin D, Dupont C . A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy. Eur J Clin Nutr. 2010; 65(2):175-83. DOI: 10.1038/ejcn.2010.250. View

11.

Fiore W, Arioli S, Guglielmetti S . The Neglected Microbial Components of Commercial Probiotic Formulations. Microorganisms. 2020; 8(8). PMC: 7464440. DOI: 10.3390/microorganisms8081177. View

12.

Gibson G, Hutkins R, Sanders M, Prescott S, Reimer R, Salminen S . Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017; 14(8):491-502. DOI: 10.1038/nrgastro.2017.75. View

13.

Tsilingiri K, Rescigno M . Postbiotics: what else?. Benef Microbes. 2012; 4(1):101-7. DOI: 10.3920/BM2012.0046. View

14.

Salminen S, Stahl B, Vinderola G, Szajewska H . Infant Formula Supplemented with Biotics: Current Knowledge and Future Perspectives. Nutrients. 2020; 12(7). PMC: 7400136. DOI: 10.3390/nu12071952. View

15.

Beghin L, Tims S, Roelofs M, Rouge C, Oozeer R, Rakza T . Fermented infant formula (with Bifidobacterium breve C50 and Streptococcus thermophilus O65) with prebiotic oligosaccharides is safe and modulates the gut microbiota towards a microbiota closer to that of breastfed infants. Clin Nutr. 2020; 40(3):778-787. DOI: 10.1016/j.clnu.2020.07.024. View

16.

Hill C, Guarner F, Reid G, Gibson G, Merenstein D, Pot B . Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11(8):506-14. DOI: 10.1038/nrgastro.2014.66. View

17.

Ashraf R, Shah N . Immune system stimulation by probiotic microorganisms. Crit Rev Food Sci Nutr. 2014; 54(7):938-56. DOI: 10.1080/10408398.2011.619671. View

18.

Sazawal S, Dhingra U, Hiremath G, Sarkar A, Dhingra P, Dutta A . Effects of Bifidobacterium lactis HN019 and prebiotic oligosaccharide added to milk on iron status, anemia, and growth among children 1 to 4 years old. J Pediatr Gastroenterol Nutr. 2010; 51(3):341-6. DOI: 10.1097/MPG.0b013e3181d98e45. View

19.

Andresen V, Gschossmann J, Layer P . Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Lancet Gastroenterol Hepatol. 2020; 5(7):658-666. DOI: 10.1016/S2468-1253(20)30056-X. View

20.

Guglielmetti S, Mora D, Gschwender M, Popp K . Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011; 33(10):1123-32. DOI: 10.1111/j.1365-2036.2011.04633.x. View